ロード中...
Intravitreal ranibizumab for the treatment of choroidal neovascularisation secondary to angioid streaks
AIMS: To assess the medium to long-term efficacy and safety of intravitreal ranibizumab for the treatment of choroidal neovascularisation (CNV) secondary to angioid streaks (AS). METHODS: A total of 12 eyes of nine patients treated with intravitreal ranibizumab (0.5 mg in 0.05 ml) for CNV secondary...
保存先:
| 主要な著者: | , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group
2012
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3443824/ https://ncbi.nlm.nih.gov/pubmed/22722486 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/eye.2012.116 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|